National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, NSW, Australia.
Euro Surveill. 2015;20(43). doi: 10.2807/1560-7917.ES.2015.20.43.30050.
Increased febrile reactions in Australian children from one influenza vaccine brand in 2010 diminished confidence in influenza immunisation, highlighting the need for improved vaccine safety surveillance. AusVaxSafety, a national vaccine safety surveillance system collected adverse events in young children for 2015 influenza vaccine brands in real time through parent/carer reports via SMS/email. Weekly cumulative data on 3,340 children demonstrated low rates of fever (4.4%) and medical attendance (1.1%). Fever was more frequent with concomitant vaccination.
2010 年,一种流感疫苗品牌在澳大利亚儿童中引起的发热反应增加,降低了人们对流感免疫接种的信心,凸显出需要加强疫苗安全监测。AusVaxSafety 是一个全国性的疫苗安全监测系统,通过家长/照顾者通过短信/电子邮件实时报告,收集 2015 年流感疫苗品牌的不良事件。3340 名儿童的每周累积数据显示,发热(4.4%)和就医(1.1%)的发生率较低。同时接种疫苗时,发热更为常见。